Abstract
Introduction

Insulin transmits its signals through a cell surface tyrosine kinase receptor, which stimulates multiple intracellular signalling events. The insulin receptor (IR) undergoes activation upon insulin binding, leading to the generation of two major intracellular signalling pathways the phosphatidylinositol 3-kinase (PI3K)/Akt and the Ras/Raf/MEK/ERK: mitogen-activated protein kinase (MAPK) pathway
. Insulin signalling in cellular mitogenesis via the MAPK pathway has been well established [3, 4] . Extracellular signal-regulated protein kinases (ERK) are activated when they are phosphorylated by MEK, which is activated by Raf [5] [6] [7] [8] . Critical cellular processes such as proliferation, growth, differentiation, cytoskeletal remodelling, migration, cell cycle progression and apoptosis are known to be mediated by the MAPK pathway [9] [10] [11] .
. In the MAPK signalling cascades, the ERK proteins are sites where diverse signals converge to elicit distinct biological responses through activation of the ERK effectors. When activated, ERK phosphorylates various downstream substrates involved in a multitude of cellular responses for mitogenesis
Upon mitogenic stimulation, ERK was re-localized from cytoplasm to nucleus [7, 12] [13] . Numerous transcription factors, including Elk-1, Egr-1, and c-Jun, are modulated by ERK in the nucleus for regulation of gene transcription [8-11, 14, 15] . The catalytically active ERK-mediated transcriptional events ultimately impinge on cell cycle elements, such as the induction of cyclinD1 for cell cycle progression [6] [7] [8] . In addition, cytoskeletal elements such as MAPs and Tau are also known to be regulated by ERK for cytoskeleton rearrangements affecting cellular morphology [16] .
. Comparison of the kinetics of ERK activation and nuclear translocation revealed that it is the active phosphorylated form of ERK that re-localizes into the nucleus
Caveolin, an integral membrane protein, is the primary protein component of caveolae membranes [17, 18] . The caveolin gene family consists of caveolin-1, -2 and -3. Caveolin-1 and -2 are expressed in most cell types, while caveolin-3 is expressed mainly in muscle cells [19] . Recent [17, 18] . Thus, caveolins are known to play an active role in a variety of cellular processes [20, 21] . Despite numerous findings of caveolin regulation in signalling, most of the studies reported have concentrated exclusively on the role of caveolin-1. Of interest, the MAPK-mediated signal cascade is negatively regulated by the relative abundance of caveolin-1 [22] [23] [24] [25] [26] [27] . The expression of caveolin-1 is significantly reduced in human breast cancer cells [22, 23] . The cyclin D1 gene is inhibited during overexpression of caveolin-1 [24] . The loss of mitogenic signalling in senescent cells is related to their up-regulation of caveolin-1 [27] [28] [29] . Caveolin-1, thus, affects the regulatory mechanism of cell growth negatively and reduces not only cell growth but also tumourigenecity.
studies suggest that caveolins function as scaffolding proteins to interact with signalling molecules like G-proteins, receptor tyrosine kinases (RTKs), Src-like kinases, eNOS, Ras and ERK
Caveolin-2, which is 38% identical and 58% similar to caveolin-1 is widely presented in many cell types [19, 30] and has been known generally for its structural role in caveolae formation [17] [18] [19] [20] [21] . [31, 32] . Although recent reports show that caveolin-2 can be phosphorylated on tyrosine 19 and 27 by c-Src [31, 32] and serine-phosphorylated on 23 and 36, likely through the action of casein kinase 2 [33] , and that caveolin-2 deficient transgenic mice have pulmonary dysfunction [34] , there have been no data demonstrating that caveolin-2, per se, can modulate signalling in a manner similar to caveolin-1. Thus, the exact physiological role of caveolin-2 remains unknown. Therefore, except for its structural role in the formation of caveolae, little is known concerning any role of caveolin-2, especially in the regulation of cell mitogenesis. In our previous study, we showed that caveolin-2 enhances the insulin-induced cell cycle in Hirc-B fibroblasts [35] [38, 39] (Fig. 1) 
Primary sequence analysis of caveolin-2 reveals that caveolin-2 contains a putative tyrosine kinase recognition motif (QLFMADDSpY) at tyrosine 19 and a conserved SH2 domain-binding motif (pYADP) at tyrosine 27
SDS-PAGE and immunoblot analysis
. Quantitative fluorescence data were exported from ImageJ generated histograms into Microsoft Excel software for further analysis. Averages and standard errors were computed over 3 or 5 images per condition for a minimum of 150 cells per condition. The DAPI staining mask was used to define the nuclear region of interest (ROI). Measurement of nuclear co-localization of caveolin-2 with ERK or pY19-caveolin-2 with phospho-ERK was performed using the Colocalization
RT-PCR analysis
Total RNA was extracted with TRIzol reagent (SolGent Co., Ltd.) according to the manufacturer's instructions. cDNA was generated using a reverse transcription kit (Accupower RT PreMix, Bioneer). The cDNA was used as the template for the subsequent PCR amplification. PCR primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH): 5Ј-ACCACCATGGA-GAAGGCTGG-3Ј and 5Ј-CTCAGTGTAGCCCAGGATGCC-3Ј; CyclinD1: 5Ј-CTGAGGAGACCTGCGCGC-3Ј and 5Ј-TCGATGTTCTGCTGGGCCT-3Ј; p21: 5Ј-ATGTCCGATCCTGGTGATGTCC-3Ј and 5Ј-TCAGGGCTTTCTTGCA-GAAGA-3Ј. PCR was performed using AccuPower PCR PreMix (Bioneer
Densitometry analysis
Chemiluminescent images of immunoblots were analysed by scanning densitometry using Kodak Gel Logic 100 Imaging System (Eastman Kodak Co.). Multiple exposure of each blot was used to obtain gray-scale images of each chemiluminescent band. Bands were visualized on a UV transilluminator and photographed
Statistical analysis
Data are expressed as mean Ϯ S.E. An unpaired Student's t-test was used to compare treatment groups with significance established at a level of P < 0.05.
Results
Insulin induces tyrosine phosphorylaion of caveolin-2
To investigate the phosphorylation of caveolin-2 and its functional significance in response to insulin, cells were treated with insulin for a detailed time-course experiment and insulin-induced tyrosine phosphorylation of caveolin-2 was characterized
Insulin increases the association of phosphotyrosine-caveolin-2 with the insulin receptor
To investigate how tyrosine phosphorylation of caveolin-2 influences in insulin signalling, we first examined the association between IR and caveolin-2 (Fig. 2) . During an insulin time course, the interaction of IR with caveolin-2 was increased to the maximum 4-fold at 10 min. (Fig. 2A) . When the interaction with phosphotyrosine-caveolin-2 was examined, 5.4-, 6.9-and 2.9-fold increases at 10, 60 and 180 min., respectively, was observed (Fig. 2B) . In contrast, the IR interaction with pY19-caveolin-2 showed no detectable changes in response to insulin (Fig. 2C) . (Fig. 3D) . Furthermore, the insulin-elicited interaction of ERK with pY19-caveolin-2 was also not changed (Fig. 3E) (Fig. 3F) . (Fig. 4) [7, 12, 13] (Fig. 6) . (Fig. 6A, panel b) . The quantitative correlation analysis showed the expected increase in the nuclear co-localization (%) from nuclear:cytoplasmic ratios of caveolin-2 with ERK staining. Interestingly, pretreatment with U0126 prevented the insulin-induced co-localization (Fig. 6A, panel c) . When we further examined insulin-induced translocation of pY19-caveolin-2 (Fig. 6B) , insulin promoted translocation of pY19-caveolin-2 to the nucleus (Fig. 6B, panel b) . The nuclear translocation of pY19-caveolin-2 was blocked by U0126 (Fig. 6B, panel c) but not affected by wortmannin treatment (Fig. 6B, panel d) Fig. 7A , the caveolin-2 siRNA duplexes effectively depleted caveolin-2 protein by over 75% of levels observed in the scramble control siRNA-transfected cells. When the caveolin-2 depleted cells were examined for the activation of ERK by insulin, the knockdown of caveolin-2 had no effect on insulin-stimulated ERK activation (Fig. 7A) (Fig. 7B) . Consistent with the result shown in Fig. 6 , the inhibition of insulin-induced nuclear translocation of ERK by U0126 was observed in the scramble control cells (Fig. 7B, panels b and c) . However, in caveolin-2 siRNA transfected cells (Fig. 7C) , insulininduced nuclear translocation of ERK was inhibited (Fig. 7C,  panel b) . As observed in Fig. 7B , panel c, the same prevention of nuclear translocation of ERK by U0126 was observed in caveolin-2 siRNA transfected cells (Fig. 7C, panel c) (Fig. 8A, lanes 7 versus 9) . Knockdown of caveolin-2 caused a significant reduction from the 14.9-fold to 8.3-fold increase in the insulin-induced c-Jun expression (Fig. 8A, lanes 3 versus 7 ) . Fig. 8A, lane 5) exhibited a complete inhibition in the c-Jun expression compared to the 5-fold increase observed by U0126 alone (Fig. 8A, lane 9 
These results show that pY19-caveolin-2 does not involve in upstream insulin signalling through direct interaction with IR. However, the results suggest that pY27-caveolin-2, another phosphotyrosine-caveolin-2, might be involved in the insulin signalling.
Insulin triggers association between pY19-caveolin-2 and phospho-ERK
We have investigated insulin-induced tyrosine phosphorylation of caveolin-2 and its interaction with phospho-ERK by immunoprecipitation analyses after cells were treated with U0126. U0126 completely abolished insulin-induced interaction of caveolin-2 with phospho-ERK (Fig. 3A). When the insulin-induced tyrosine phosphorylation of caveolin-2 was analysed, pY19-caveolin-2 was 2-fold increased but U0126 suppressed the phosphorylation to basal level. The interaction of ERK with pY19-caveolin-2 was increased 2-fold by insulin but decreased below the basal level by U0126 (Fig. 3B). Of interest, the basal interaction of phospho-ERK with pY19-caveolin-2 was increased by insulin (Fig. 3C). These data suggest that insulin promotes phosphorylation of caveolin-2 on tyrosine 19 and ERK in the caveolin-2-ERK complex. When the effect of wortmannin on the insulin-induced caveolin-2 interaction with ERK was examined, the interaction of caveolin-2 with phospho-ERK and phosphorylation of pY19-caveolin-2 showed no significant changes
Nonidet P-40 and n-octylglucoside solubilize caveolin-2 while retaining caveolin-2-ERK interaction
Insulin promotes nuclear co-localization of pY19-caveolin-2 and phospho-ERK
ERK activation is characterized by its nuclear translocation
. Since insulin caused the association between pY19-caveolin-2 and phospho-ERK as demonstrated above (Figs 3-5), we next investigated if the complex translocates together to the nucleus in response to insulin. Immunofluorescence labelling for caveolin-2, ERK, pY19-caveolin-2 and nucleus was performed after cells were treated with U0126 or wortmannin
Co-localization of caveolin-2 and ERK to the nucleus was evident by insulin
These immunostaining results were further confirmed by subcellular fractionation, which demonstrate that both phospho-ERK and pY19-caveolin-2 localize to nucleus in response to insulin (Fig. 6C). Consistent with the immunofluorescence microscopy findings, U0126 prevented the insulin-induced nuclear translocation of pY19-caveolin-2 with phospho-ERK but wortmannin did not affect the translocation (Fig. 6C). Our data therefore verify that insulin triggers phosphorylation of pY19-caveolin-2 and ERK in caveolin-2-ERK complex and co-localizes the complex to the nucleus.
Depletion of caveolin-2 impairs nuclear translocation of ERK by insulin without affecting ERK activation
To evaluate the role of caveolin-2 in the MAPK signalling pathway and to explore further the mechanism underlying caveolin-2-mediated ERK activation by insulin, the effects of caveolin-2 siRNA on insulin-stimulated ERK phosphorylation and nuclear translocation were examined by transfecting cells with synthetic siRNA duplexes. As shown in
. However, when caveolin-2 tyrosine 19 was mutated to alanine, the inhibition of insulininduced ERK activation was observed (Fig. 5). Thus, it appears that pY19-caveolin-2 influences the activation of ERK.
Since it has been reported that activation of MAPK is required for its nuclear translocation [7, 12, 13], we next investigated the effect of caveolin-2 siRNA on translocation of the activated ERK by insulin to nucleus by immunofluorescence analysis
siRNAs against caveolin-2 attenuate MAPK-mediated c-Jun expression and cell proliferation by insulin
To determine whether down-regulation of caveolin-2 affects the expression of c-Jun, caveolin-2 siRNA was introduced to cells. In whole cell lysates, insulin-induced 14.9-fold increase of c-Jun expression was suppressed down to a 5-fold increase by U0126
Fig. 6 Effects of U0126 and wortmannin on insulin-induced nuclear co-localization of pY19-caveolin-2 with phospho-ERK. (A) Confluent Hirc-B fibroblast monolayers grown on coverslips were left untreated (C); (a), or challenged for 10 min. with 100 nM insulin in the absence (I); (b) and presence of 10 M U0126 for 2 hrs (UI); (c). Cells were then fixed, permeabilized and stained with anti-caveolin-2 antibody followed by TRITC-conjugated antibody, and anti-ERK antibody followed by FITC-conjugated antibody as described under 'Materials and Methods
Importantly, cells depleted of caveolin-2 and further treated with U0126 (
). These results reveal that caveolin-2 is involved in the MAPK-mediated c-Jun expression in response to insulin. Collectively, these data demonstrate that caveolin-2 downregulation prevents the nuclear targeting of ERK and in turn leads to a reduction of c-Jun expression in response to insulin. To ascertain whether insulin-triggered cell proliferation can be influenced by caveolin-2 in MAPK signalling, the effect of caveolin-2 depletion on the entry of cells into S phase was investigated. Cell proliferation was determined by counting the number of viable cells and BrdU labelling following insulin treatment. When cells were treated with both U0126 and insulin, U0126 caused an almost 40% reduction from the initial insulin-stimulated 60.6% incorporation of BrdU (data not shown). Remarkably, caveolin-2 siRNA transfection resulted in a significant decrease (42%) in
BrdU labelling as compared to the scramble control with 70% increase in response to insulin (Fig. 8B) . Thus, these data demonstrate that insulin-induced BrdU incorporation is regulated by caveolin-2 in cell proliferation. (Fig. 9, A and B,  respectively) . To determine whether caveolin-2 is required for the ERK-mediated cell cycle progression, caveolin-2 siRNAs were transfected. As shown in Fig. 9C, lanes 2 versus 6, caveolin-2 depleted cells exhibited a 2-fold reduction in the mRNA levels of cyclinD1 as compared to the scramble control in response to insulin. When caveolin-2-depleted cells were pretreated with U0126, however, the elevation in insulin-induced cyclinD1 mRNA levels of the scramble control cells was completely repressed (Fig. 9C, lanes  4 versus 8) . Thus, these data demonstrate that caveolin-2 positively regulates ERK-mediated cell cycle progression by insulin. [8] . When cells were treated with U0126 to verify whether the attenuation of p21 mRNAs was mediated by MAPK, no significant change in p21 mRNAs level by U0126 was detected (Fig. 9D) , indicating that p21 is not related to MAPK signalling. In addition, caveolin-2 siRNAs also did not cause any significant changes in the mRNA levels (data not shown). Thus, our data suggest that p21 is regulated independently of caveolin-2-mediated MAPK signalling pathway. (Fig. 10A, panel b) . Addition of CCD or LatB evidently abrogated insulin-induced nuclear co-localization of pY19-caveolin-2 with phospho-ERK (Fig. 10A, panels d and [42, 43] . CCD and LatB, actin depolymerizing agents prevented stretch-induced ERK activation and nuclear translocation in cardiomyocytes and vascular smooth muscle cells [44, 45] . However, CCD and LatB failed to influence ERK phosphorylation or translocation of ERK to the nucleus in smooth muscle cell mitogenesis caused by serotonin [46] . Our 
Depletion of caveolin-2 attenuates MAPK-mediated cell cycle progression by insulin
To gain insight into the signalling events that link caveolin-2-mediated ERK activation to the cell cycle regulatory machinery, we investigated the involvement of caveolin-2 in ERK-
It is well known that ERK indirectly controls the activity of cell cycle regulators, such as cyclins, cyclin-dependent kinases (cdks), and their inhibitors including p21
The actin cytoskeleton-dependent pathway is required for pY19-caveolin-2-mediated phospho-ERK nuclear translocation by insulin
To test whether actin cytoskeleton is involved in the insulininduced nuclear localization of pY19-caveolin-2 with phospho-ERK, cells were treated with CCD or LatB. Application of insulin led to
